| Structure |
Chemical Name |
CAS |
MF |
![2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジル]メチル]チオ]-1H-ベンゾイミダゾール](/CAS/GIF/103577-40-8.gif) |
2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジル]メチル]チオ]-1H-ベンゾイミダゾール |
103577-40-8 |
C16H14F3N3OS |
 |
Parecoxib Sodium Impurity 14 |
1709956-89-7 |
C19H18N2O4S |
 |
Ciprofloxacin Impurity D HCl |
526204-10-4 |
C17H18FN3O3 |
 |
Donepezil Impurity |
36159-03-2 |
C22H22O5 |
 |
Levofloxacin Impurity 9 |
1797099-76-3 |
C18H20FN3O4 |
 |
Flurbiprofen IMpurity E |
|
|
 |
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
 |
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
![2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid](/) |
2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
|
|
 |
Pyridine, 3-Methoxy-2-Methyl-4-nitro-, 1-oxide |
15931-25-6 |
C7H8N2O4 |
 |
Oxacillin sodium EP impurity B |
|
|
 |
Carfilzomib Impurity C |
|
|
 |
S 00218 |
92700-82-8 |
C15H22N2O4 |
 |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |
![sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Donepezil Impurity |
844694-84-4 |
C24H31NO2 |
 |
AvatrombopagImpurity42 |
|
|
 |
Procaterol Impurity 4 |
63235-39-2 |
C16H20N2O3 |
![(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid](/CAS/GIF/1048973-04-1.gif) |
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid |
1048973-04-1 |
C24H34O5 |
 |
Etoricoxib iMpurity 2 |
|
|
![(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol](/CAS/20180808/GIF/915095-96-4.gif) |
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
 |
Baricitinib Impurity 5 |
|
|
 |
Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) |
55198-89-5 |
C15H10ClN3O3 |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-28-2.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
 |
Levofloxacin Impurity 11 |
106939-42-8 |
C9H9F2NO |
 |
Parecoxib Impurity 18 |
|
|
 |
Defluoro Paroxetine Hydrochloride |
1394842-91-1 |
|
![2-[3-カルボキシ-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸](/CAS/GIF/1239233-87-4.gif) |
2-[3-カルボキシ-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸 |
1239233-87-4 |
C16H17NO5S |
 |
Levothyroxine Sodium impurity |
27566-09-2 |
C14H21NO4 |
![3S,4R-4-[phenyl-1-methylpiperidinyl] methanol](/CAS/20180906/GIF/176022-03-0.gif) |
3S,4R-4-[phenyl-1-methylpiperidinyl] methanol |
176022-03-0 |
C13H19NO |
![5-[(S)-2-アミノ-3-ヒドロキシプロピル]-3-[2-(ジメチルアミノ)エチル]-1H-インドール](/CAS/20150408/GIF/139264-69-0.gif) |
5-[(S)-2-アミノ-3-ヒドロキシプロピル]-3-[2-(ジメチルアミノ)エチル]-1H-インドール |
139264-69-0 |
C15H23N3O |
 |
Linagliptin Impurity CD10925 |
|
|
 |
Bumetanide Impurity 14 |
1431501-10-8 |
C21H27NO3 |
 |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
 |
Sodium chloride standard titration solution c(NaCl)=0.1 mol/L |
|
|
 |
(R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
178422-39-4 |
C14H15N5O6S2 |
 |
Fondaparinux sodiuM iMpurity 1 |
348625-84-3 |
C13H21NO19S3 |
 |
Cytidine,N-benzoyl-2^-C-Methyl-,3^,5^-dibenzoate(9CI) |
863329-64-0 |
C31H27N3O8 |
 |
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
 |
(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol |
1384080-56-1 |
C9H15NOS |
 |
Deoxy Fesoterodine |
895137-81-2 |
C26H37NO2 |
 |
Metronidazole IMpurity D |
|
|
 |
Empagliflozin (R)-Isomer |
864070-43-9 |
C23H27ClO7 |
 |
7-Bromo Epinastine |
1217052-16-8 |
C16H14BrN3 |
 |
Latanoprost Impurity 3 |
2278245-92-2 |
C27H41BrO5 |
 |
Olprinone Impurity 7 |
2236020-10-1 |
C9H10N2 |
 |
Pemetrexed |
|
|
 |
Aprepitant iMpurity 37 |
|
|
 |
Metronidazole impurity A |
|
|
 |
Empagliflozin Impurity 79 |
|
|
 |
Losartan IsoMer IMpurity, PotassiuM Salt |
860644-28-6 |
C22H22ClKN6O |
![1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)-](/CAS/20180808/GIF/1236033-03-6.gif) |
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-(hydroxyMethyl)-7H-pyrrolo[2,3-d]pyriMidin-4-yl]-,(βR)- |
1236033-03-6 |
C18H20N6O |
 |
Olanzapine Impurity 22 |
|
C17H20N4S |
 |
5-ヒドロキシ-6-メトキシ-1-インダノン |
127399-78-4 |
C10H10O3 |
 |
IMidafenacin Related CoMpound 1 (4-(1H-IMidzol-1-yl)-2,2-DiphenylbutanaMide) |
170105-20-1 |
C19H19N3O |
 |
Lercanidipine Impurity 25 |
100427-22-3 |
C36H41N3O6 |
 |
Vecuronium Bromide EP Impurity F |
18668-29-6 |
C26H41NO3 |
 |
trans-アポビンカミン酸エチル |
77549-94-1 |
C22H26N2O2 |
 |
Everolimus Impurity 2 |
|
|
 |
(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((R)-tetrahydrofuran- 3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol |
|
C23H27ClO7 |
![1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide](/CAS/GIF/1292904-74-5.gif) |
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide |
1292904-74-5 |
C20H22FN3O4.BrH |
 |
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
 |
Apremilast Impurity 15 |
2096492-41-8 |
C22H26N2O8S |
![1-デオキシ-1-[[3,4-ジメチル-2-(フェニルアゾ)フェニル]アミノ]-D-リビトール](/CAS/20200611/GIF/21037-25-2.gif) |
1-デオキシ-1-[[3,4-ジメチル-2-(フェニルアゾ)フェニル]アミノ]-D-リビトール |
21037-25-2 |
C19H25N3O4 |
 |
Erlotinib Impurity 23 |
2021249-11-4 |
C23H18F6N6O |
 |
5-Chloro-1-methyl-4-nitroimidazole |
|
C4H4ClN3O2 |
 |
(S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-hydroxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid |
|
|
 |
Canagliflozin Impurity 32 |
|
|
 |
4-O-(カルボキシメチル)リファマイシン |
13929-35-6 |
C39H49NO14 |
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride](/CAS/20150408/GIF/1038924-71-8.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
 |
2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid
(Diketopiperazine) |
|
C29H42N8O18S4 |
 |
(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-L-cysteine |
2238849-52-8 |
C13H15N3O3S |
 |
Eltrombopag Impurity 2 |
|
|
 |
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)oxy)naphthalen-1-ol |
|
|
 |
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
![3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester](/CAS/20210305/GIF/221446-45-3.gif) |
3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester |
221446-45-3 |
C20H23Cl2NO5 |
 |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/629652-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
629652-44-4 |
C22H19ClN2O5 |
 |
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
 |
Cyclopropane, nitroso- |
28017-92-7 |
C3H5NO |
 |
モキシフロキサシンメチルエステル |
721970-35-0 |
C22H26FN3O4 |
 |
4-(4-fluorobenzoyl)-3-(hydroxyMethyl)benzonitrile |
260371-16-2 |
C15H10FNO2 |
 |
tert-butyl (3R,5R)-7-(1-((3R,5R)-7-(tert-butoxy)-3,5-dihydroxy-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamido)-3,5-dihydroxyheptanoate |
|
|
 |
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
![8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide](/CAS/20211123/GIF/2043655-58-7.gif) |
8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide |
2043655-58-7 |
C14H19Cl3N2 |
 |
Ibrutinib Impurity 11 |
|
C27H31N7O2 |
 |
Pralatrexate Impurity 14 |
|
|
 |
(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid |
40038-46-8 |
C13H10N2O3 |
 |
Juncusol 7-O-glucoside |
175094-15-2 |
C24H28O7 |
 |
Iopamidol Impurity K |
1788899-70-6 |
C17H23I2N3O8 |
 |
(S)-dimethyl 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioate |
67676-60-2 |
C22H27ClN8O5 |
 |
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
 |
Ibuprofen IPA impurity |
|
|
 |
Nisoldipine Related Compound II |
|
|
 |
Miglitol Isomer impurities C |
|
|
 |
Olaparib Impurity F |
|
|
 |
(1R,3aR,7aR)-7a-Methyl-1-((R)-6-Methylheptan-2-yl)hexahydro-1H-inden-4(2H)-one |
66251-18-1 |
C18H32O |
 |
Dabrafenib Impurity 1 |
1907654-22-1 |
C24H21F3N4O3S2 |
![[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy-](/CAS/20210305/GIF/1242047-99-9.gif) |
[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy- |
1242047-99-9 |
C28H43ClN6O4 |
 |
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |